Correction: SGLT2 inhibitor use and disparities in all-cause mortality in type 2 diabetes: insights from a multi-ethnic population.

Chepulis L, Gan H, Simmons D, Rodrigues M, Keenan R, Murphy R, Kenealy T, Te Karu L, Magliano D, Scott-Jones J, Moffitt A, Lao C, Lawrenson R, Paul RG

Open source

DOI
10.1007/s00125-026-06752-z
Published
2026 Aug
Container
Diabetologia
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00125-026-06752-z,
  title = {Correction: SGLT2 inhibitor use and disparities in all-cause mortality in type 2 diabetes: insights from a multi-ethnic population.},
  author = {Chepulis L and Gan H and Simmons D and Rodrigues M and Keenan R and Murphy R and Kenealy T and Te Karu L and Magliano D and Scott-Jones J and Moffitt A and Lao C and Lawrenson R and Paul RG},
  year = {2026},
  journal = {Diabetologia},
  doi = {10.1007/s00125-026-06752-z},
  url = {https://doi.org/10.1007/s00125-026-06752-z}
}

RIS

TY  - JOUR
TI  - Correction: SGLT2 inhibitor use and disparities in all-cause mortality in type 2 diabetes: insights from a multi-ethnic population.
AU  - Chepulis L
AU  - Gan H
AU  - Simmons D
AU  - Rodrigues M
AU  - Keenan R
AU  - Murphy R
AU  - Kenealy T
AU  - Te Karu L
AU  - Magliano D
AU  - Scott-Jones J
AU  - Moffitt A
AU  - Lao C
AU  - Lawrenson R
AU  - Paul RG
PY  - 2026
JO  - Diabetologia
DO  - 10.1007/s00125-026-06752-z
UR  - https://doi.org/10.1007/s00125-026-06752-z
ER  - 

APA

L, C., H, G., D, S., M, R., R, K., R, M., T, K., L, T. K., D, M., J, S., A, M., C, L., R, L., & RG, P. (2026). Correction: SGLT2 inhibitor use and disparities in all-cause mortality in type 2 diabetes: insights from a multi-ethnic population.. Diabetologia. https://doi.org/10.1007/s00125-026-06752-z

Source records